Congress faces a crowded agenda this fall comprised of must-pass policy initiatives and potential political messaging opportunities in the lead up to the November midterm elections. With control of both chambers at stake, the...more
9/9/2022
/ Abortion ,
Biden Administration ,
Continuing Resolution ,
Federal Funding ,
Food and Drug Administration (FDA) ,
Health Insurance ,
Healthcare ,
Healthcare Reform ,
Life Sciences ,
Medicare ,
OMB ,
Patient Access ,
Public Policy ,
Regulatory Agenda ,
Telehealth
Recent hearings by Senate and House committees and a scheduled markup underscore Congress' continued commitment to eliminating barriers that are slowing the development of effective drugs, devices, and biologics so that...more